Učitavanje...
Sunitinib rechallenge with dose escalation in progressive metastatic renal cell carcinoma: A case report and literature review
RATIONALE: We aimed to present a case of sunitinib rechallenge with dosage escalation after disease progression, hopefully, providing an optional approach to the personalized medication management of progressive metastatic renal cell carcinoma (mRCC). PATIENT CONCERNS: The patient was admitted to ho...
Spremljeno u:
| Izdano u: | Medicine (Baltimore) |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Health
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081141/ https://ncbi.nlm.nih.gov/pubmed/30075524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011565 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|